Lipoma Clinical Trials

4 recruitingLast updated: May 4, 2026

Lipoma Trials at a Glance

9 actively recruiting trials for lipoma are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Cincinnati, and Florence. Lead sponsors running lipoma studies include Children's Hospital Medical Center, Cincinnati, Columbia University, and Biorek S.R.L..

Browse lipoma trials by phase

Treatments under study

About Lipoma Clinical Trials

Looking for clinical trials for Lipoma? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lipoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lipoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride

Lipoma
West Virginia University20 enrolled1 locationNCT06820164
Recruiting
Phase 1

Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

LipomaSubmental Fullness
Glonova Pharma Co., Ltd56 enrolled2 locationsNCT07237425
Recruiting
Phase 2

Ivonescimab in the Treatment of Multiple Advanced Tumors

Urothelial CarcinomaSarcomaKidney Cancer+16 more
Fudan University400 enrolled1 locationNCT06683846
Recruiting
Not Applicable

RFA for Superficial Lipomas

Lipoma
Columbia University10 enrolled1 locationNCT06903208
Recruiting
Not Applicable

Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas

Lipoma
Espad Pharmed10 enrolled2 locationsNCT07014163
Recruiting
Not Applicable

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

LiposarcomaAtypical Lipomatous Tumor
Institut du Cancer de Montpellier - Val d'Aurelle158 enrolled1 locationNCT04224064
Recruiting

Identification of Biomarkers for Patients with Vascular Anomalies

Vascular AnomalyKlippel Trenaunay SyndromeKaposiform Hemangioendothelioma+4 more
Children's Hospital Medical Center, Cincinnati1,000 enrolled2 locationsNCT03001180
Recruiting

Biomarkers of Renal Cancer

Renal Cell CarcinomaTumor, SolidOncocytoma+1 more
Biorek S.R.L.1,000 enrolled4 locationsNCT05785052
Recruiting

Use of the GPX Embolic Device in Patients Requiring Embolization

VaricoceleRenal or hepatic tumor requiring pre-operative embolizationNeed for coil-assisted branch artery embolization pre-endovascular aneurysm repair (EVAR)+5 more
Fluidx Medical Technology, LLC20 enrolled2 locationsACTRN12620001194954